ATE527353T1 - Pdgf-bindendes polypeptid aus protein a - Google Patents

Pdgf-bindendes polypeptid aus protein a

Info

Publication number
ATE527353T1
ATE527353T1 AT08862011T AT08862011T ATE527353T1 AT E527353 T1 ATE527353 T1 AT E527353T1 AT 08862011 T AT08862011 T AT 08862011T AT 08862011 T AT08862011 T AT 08862011T AT E527353 T1 ATE527353 T1 AT E527353T1
Authority
AT
Austria
Prior art keywords
pdgf
binding polypeptide
protein
growth factor
factor receptor
Prior art date
Application number
AT08862011T
Other languages
English (en)
Inventor
Malin Lindborg
Elin Gunneriusson
Christofer Lendel
Original Assignee
Affibody Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/002,972 external-priority patent/US8937047B2/en
Priority claimed from EP07150394A external-priority patent/EP2077272A1/de
Application filed by Affibody Ab filed Critical Affibody Ab
Application granted granted Critical
Publication of ATE527353T1 publication Critical patent/ATE527353T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT08862011T 2007-12-19 2008-12-17 Pdgf-bindendes polypeptid aus protein a ATE527353T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12/002,972 US8937047B2 (en) 2007-12-19 2007-12-19 Biokinetics of fast-clearing polypeptides
EP07150394A EP2077272A1 (de) 2007-12-21 2007-12-21 Polypeptid-Bibliothek mit vorbestimmtem Gerüst
US917107P 2007-12-26 2007-12-26
PCT/EP2008/010776 WO2009077175A1 (en) 2007-12-19 2008-12-17 Polypeptide derived from protein a and able to bind pdgf

Publications (1)

Publication Number Publication Date
ATE527353T1 true ATE527353T1 (de) 2011-10-15

Family

ID=40547476

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08862011T ATE527353T1 (de) 2007-12-19 2008-12-17 Pdgf-bindendes polypeptid aus protein a

Country Status (5)

Country Link
EP (1) EP2231860B1 (de)
AT (1) ATE527353T1 (de)
DK (1) DK2231860T3 (de)
ES (1) ES2373832T3 (de)
WO (1) WO2009077175A1 (de)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9829494B2 (en) 2005-12-01 2017-11-28 Adrenomed Ag Methods of treatment using ADM antibodies
US8124725B2 (en) * 2007-12-19 2012-02-28 General Electric Company PDGF-Rβ binders
EP2077272A1 (de) 2007-12-21 2009-07-08 Affibody AB Polypeptid-Bibliothek mit vorbestimmtem Gerüst
EP2072525A1 (de) 2007-12-21 2009-06-24 Affibody AB Neue Polypeptide mit Bindungsaffinität für HER2
US20120165650A1 (en) 2010-12-22 2012-06-28 General Electric Company Her2 binders
ES2751492T3 (es) 2011-11-16 2020-03-31 Adrenomed Ag Anticuerpo anti-adrenomedulina (ADM) o fragmento de anticuerpo anti-ADM o armazón no Ig anti-ADM para uso en la terapia de una enfermedad aguda o una afección aguda de un paciente para estabilizar la circulación
NZ624873A (en) 2011-11-16 2016-07-29 Adrenomed Ag Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic or acute disease or acute condition
PL2594587T3 (pl) 2011-11-16 2014-11-28 Adrenomed Ag Przeciwciało przeciwko adrenomedulinie (ADM) lub fragment przeciwciała anty-ADM lub szkielet białkowy niestanowiący Ig anty-ADM do zmniejszenia ryzyka śmierci u pacjenta cierpiącego na chorobę przewlekłą lub ostrą lub stan ostry
HRP20170427T1 (hr) 2011-11-16 2017-06-16 Sphingotec Gmbh Testovi na adrenomedulin i postupci određivanja zrelog adrenomedulina
KR102249078B1 (ko) 2011-11-16 2021-05-10 아드레노메드 아게 요법에 사용하기 위한 항-아드레노메둘린 (adm) 항체 또는 항-adm 항체 단편 또는 항-adm 비-ig 스캐폴드
SG10201802054TA (en) 2011-11-16 2018-05-30 Adrenomed Ag Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for regulating the fluid balance in a patient having a chronic or acute disease
EP3511339B1 (de) 2012-02-20 2025-04-09 IPC Research, LLC An die menschliche komplementkomponente c5 bindende polypeptide
CN103308673B (zh) 2012-03-08 2017-05-31 思芬构技术有限公司 用于预测雌性对象中发生心血管事件的风险的方法
CN103308670B (zh) 2012-03-08 2017-06-09 思芬构技术有限公司 用于预测对象患糖尿病和/或代谢综合征的风险的方法
CN103308689B (zh) 2012-03-08 2017-04-12 思芬构技术有限公司 用于预测雌性对象中患上癌症的风险或诊断癌症的方法
DK2904403T3 (en) 2012-10-02 2018-07-16 Sphingotec Gmbh PROCEDURE FOR DIAGNOSTICATION OR MONITORING OF Kidney Function or Diagnosis of Kidney Function
WO2014053586A1 (en) 2012-10-05 2014-04-10 Affibody Ab Her3 binding polypeptides
ES2639099T3 (es) 2012-10-25 2017-10-25 Affibody Ab Polipéptido de unión a albúmina
PL2912051T3 (pl) * 2012-10-25 2018-08-31 Affibody Ab Sposób rozdzielania białek zawierających domenę wiążącą albuminę
WO2014096163A1 (en) 2012-12-19 2014-06-26 Affibody Ab New polypeptides
RU2677895C2 (ru) 2013-01-08 2019-01-22 Сфинготек Гмбх Уровни гормона роста натощак в качестве прогностического маркера сердечно-сосудистого риска
KR102191654B1 (ko) 2013-03-15 2020-12-16 애피바디 에이비 신규 폴리펩티드
SG10201800309SA (en) 2013-03-20 2018-02-27 Sphingotec Gmbh Adrenomedullin to guide therapy of blood pressure decline
JP6767865B2 (ja) * 2013-08-28 2020-10-14 スウェディッシュ・オーファン・バイオヴィトラム・アーベー（ペーウーベーエル） ヒト補体ｃ５に結合する安定なポリペプチド
AU2014314214C1 (en) 2013-08-28 2019-01-24 Affibody Ab Binding polypeptides having a mutated scaffold
CN106536567A (zh) 2014-06-13 2017-03-22 阿菲博迪公司 新型多肽
CN106488930B (zh) * 2014-06-13 2021-11-02 阿菲博迪公司 新型多肽
EP3193930B1 (de) 2014-09-17 2019-06-19 Affibody AB Neue polypeptide
EP3002589A1 (de) 2014-10-01 2016-04-06 sphingotec GmbH Verfahren zur stratifizierung einer frau zur hormonersatztherapie
PT3245224T (pt) 2015-01-12 2020-10-08 Affibody Ab Polipéptidos de ligação a il-17a
WO2016170023A1 (en) 2015-04-24 2016-10-27 Sphingotec Gmbh A method for predicting the risk of incidence of chronic kidney disease
WO2017072280A1 (en) 2015-10-30 2017-05-04 Affibody Ab New polypeptide having affinity to pd-l1
EP3368557B1 (de) 2015-10-30 2026-03-25 Affibody AB Neues polypeptid
CH713803B1 (de) 2016-04-21 2023-08-15 4TEEN4 Pharmaceuticals GmbH Verfahren zur Diagnose durch Bestimmung von DPP3, Hemmer der Aktivität von DPP3 und Zusammensetzung mit einem Hemmer.
EP3474887A1 (de) 2016-06-27 2019-05-01 AiCuris Anti-infective Cures GmbH Hcmv-eingangsinhibitoren
JP7191813B2 (ja) 2016-07-08 2022-12-19 シュピーンゴテック ゲゼルシャフト ミット ベシュレンクテル ハフツング 急性心不全に罹患している対象におけるうっ血を評価するためのアドレノメデュリン
EP3309550A1 (de) 2016-10-12 2018-04-18 sphingotec GmbH Verfahren zum nachweis von apolipoprotein e4
EP3339324A1 (de) 2016-12-22 2018-06-27 sphingotec GmbH Anti-adrenomedullin (adm)-antikörper oder anti-adm antikörperfragment oder anti-adm-nicht-ig-gerüst zur verwendung in einer intervention und therapie von verstopfung bei einem darauf angewiesenen patienten
MX2019007107A (es) 2016-12-16 2019-10-21 Adrenomed Ag Anticuerpo anti-adrenomedulina (adm) o fragmento de anticuerpo anti-adm o supercontigo sin ig anti-adm para su uso en intervencion y terapia de congestion en un paciente con necesidad del mismo.
UY37651A (es) 2017-03-31 2018-10-31 Swedish Orphan Biovitrum Ab Publ Polipéptido de unión al il-1r-i
BR112019024966A2 (pt) 2017-05-30 2020-06-23 Sphingotec Gmbh Método para diagnosticar ou monitorar a função renal ou diagnosticar a disfunção renal
CN109400711B (zh) * 2017-05-31 2022-02-08 四川大学华西医院 一种PDGFRβ靶向性肿瘤坏死因子相关凋亡诱导配体变异体及其制备方法和用途
WO2019057992A2 (en) 2017-09-25 2019-03-28 Adrenomed Ag ANTI-ADRENOMEDULIN (ADM) BINDER FOR USE IN TREATING OR PREVENTING THE SYMPTOMS OF A DISEASE
BR112020005682A2 (pt) 2017-10-18 2020-10-20 Adrenomed Ag monitoração de terapia sob tratamento com um aglutinante de antiadrenomedulina (adm)
EP3701266A1 (de) 2017-10-24 2020-09-02 sphingotec GmbH Selenoprotein zur vorhersage eines ersten kardiovaskulären ereignisses
MY202502A (en) 2017-10-25 2024-05-01 4TEEN4 Pharmaceuticals GmbH Dpp3 binder directed to and binding to specific dpp3-epitopes and its use in the prevention or treatment of diseases / acute conditions that are associated with oxidative stress
EP3749959A1 (de) 2018-02-08 2020-12-16 sphingotec GmbH Adrenomedullin (adm) zur diagnose und/oder vorhersage von demenz und anti-adrenomedullin-bindemittel zur verwendung in der therapie oder prävention von demenz
EP3569614A1 (de) 2018-05-18 2019-11-20 Julius-Maximilians-Universität Würzburg Verbindungen und verfahren zur immobilisierung von myostatin-inhibitoren auf der extrazellulären matrix durch transglutaminase
EP3586865A1 (de) 2018-06-21 2020-01-01 Charité - Universitätsmedizin Berlin Ergänzende anaphylatoxinbindemittel und deren verwendung in der behandlung einer person mit okularer wunde und/oder fibrose
AU2019408553A1 (en) 2018-12-20 2021-06-17 Sphingotec Gmbh Selenoprotein P in heart failure
WO2020128039A2 (en) 2018-12-21 2020-06-25 4TEEN4 Pharmaceuticals GmbH Therapy guidance and/or therapy monitoring for a treatment with angiotensin-receptor-agonist and/or a precursor thereof
EP4014049A1 (de) 2019-08-15 2022-06-22 sphingotec GmbH Verfahren zur diagnose oder überwachung der nierenfunktion oder zur diagnose von nierenfunktionsstörungen bei pädiatrischen patienten
EP4552649A3 (de) 2019-08-30 2025-06-25 4TEEN4 Pharmaceuticals GmbH Therapieführung und/oder therapieüberwachung zur behandlung von schock
US20220389066A1 (en) 2019-11-05 2022-12-08 Affibody Ab Polypeptides
EP3871689A1 (de) 2020-02-26 2021-09-01 sphingotec GmbH Anti-adm-antikörper, die an den freien n-terminus binden, für einen beschleunigten übergang von adm-gly zu bio-adm bei patienten mit einem adm-gly/bio-adm-verhältnis über einem schwellenwert und kombination mit vitamin c
AU2021228207A1 (en) 2020-02-27 2022-10-20 4TEEN4 Pharmaceuticals GmbH DPP3 for therapy guidance, monitoring and stratification of nt-ADM antibodies in patients with shock
WO2021170880A2 (en) 2020-02-27 2021-09-02 Adrenomed Ag Anti-adrenomedullin (adm) binder for use in therapy of patients in shock
CA3168978A1 (en) 2020-02-27 2021-09-02 Andreas Bergmann Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy or prevention of shock
MX2022011583A (es) 2020-03-16 2022-10-18 4TEEN4 Pharmaceuticals GmbH Dpp3 en pacientes infectados con coronavirus.
EP4121772A1 (de) 2020-03-16 2023-01-25 sphingotec GmbH Proadrenomedullin oder fragment davon bei patienten mit coronavirusinfektion und behandlungen mit bindemittel gegen adrenomedullin
EP3922993A1 (de) 2020-06-12 2021-12-15 4TEEN4 Pharmaceuticals GmbH Dpp3 bei patienten, die mit coronavirus infiziert sind
EP4023218A1 (de) 2020-12-02 2022-07-06 S-Form Pharma Kombinationstherapie für patienten mit akuter und/oder anhaltender dyspnoe
WO2022263648A1 (en) 2021-06-18 2022-12-22 Sphingotec Gmbh A method for predicting sepsis and septic shock
KR20240041912A (ko) 2021-06-29 2024-04-01 베리솔 게엠베하 체액내 셀레늄 결핍을 식별하기 위한 복합 바이오마커
CN118632866A (zh) 2022-02-08 2024-09-10 阿菲博迪公司 结合胸腺基质淋巴细胞生成素的蛋白质z变体及其医疗用途
CN119072492A (zh) 2022-03-15 2024-12-03 艾德里诺医药公司 抗肾上腺髓质素（adm）抗体或抗adm抗体片段的稳定水性制剂
EP4562430A1 (de) 2022-07-29 2025-06-04 4TEEN4 Pharmaceuticals GmbH Vorhersage einer erhöhung von dpp3 bei einem patienten mit septischem schock
JP2025541138A (ja) 2022-12-15 2025-12-18 ４ティーン４ ファーマシューティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング 重篤な患者における肺機能の改善のためのｄｐｐ３阻害剤
CN120731367A (zh) 2023-03-17 2025-09-30 Pam治疗诊断有限公司 肽基甘氨酸α-酰胺化单加氧酶（PAM）的测定方法及其诊断用途
EP4687942A1 (de) 2023-03-29 2026-02-11 4TEEN4 Pharmaceuticals GmbH Dpp3-hemmer für herzmuskelschutz und prävention von myokardläsionen bei kritisch kranken patienten mit blutdruckabfall
EP4694978A1 (de) 2023-04-11 2026-02-18 Antaros Tracer AB Arzneimittelabgabesysteme
AU2024265436A1 (en) 2023-05-04 2025-11-06 Affibody Ab New polypeptide
WO2025068313A1 (en) 2023-09-25 2025-04-03 Sphingotec Gmbh A method for early diagnosis, early prediction, monitoring or prediction of severity of reduced graft function in a kidney transplantation patient
WO2025229075A1 (en) 2024-05-03 2025-11-06 Sphingotec Gmbh A method for the specific determination of proenkephalin fragment 119-159
WO2025248139A1 (en) 2024-05-31 2025-12-04 4TEEN4 Pharmaceuticals GmbH Use of adrenomedullin or fragments thereof in the treatment of a patient in need thereof
EP4675277A1 (de) 2024-07-05 2026-01-07 Predemtec AG Verfahren zur diagnose von morbus alzheimer oder zur bestimmung des risikos des leidens an morbus alzheimer
WO2026046978A1 (en) 2024-08-26 2026-03-05 Pam Theragnostics Gmbh Anti-adm antibodies, anti-adm antibody fragment or anti-adm non-ig scaffold for therapy or prevention of immune effector cell therapy side effects
WO2026046968A1 (en) 2024-08-26 2026-03-05 4TEEN4 Pharmaceuticals GmbH Dpp3 binders for the treatment of endothelial dysfunction

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE509359C2 (sv) 1989-08-01 1999-01-18 Cemu Bioteknik Ab Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
US5443072A (en) * 1994-01-21 1995-08-22 Kagan; Andrew Miniature disposable blood flow monitor

Also Published As

Publication number Publication date
EP2231860B1 (de) 2011-10-05
WO2009077175A1 (en) 2009-06-25
DK2231860T3 (da) 2011-12-05
ES2373832T3 (es) 2012-02-09
EP2231860A1 (de) 2010-09-29

Similar Documents

Publication Publication Date Title
ATE527353T1 (de) Pdgf-bindendes polypeptid aus protein a
UA103154C2 (uk) Hla-a*1101-обмежений пептид wt1 і фармацевтична композиція, яка містить його
EA201100546A1 (ru) Полипептиды, вариабельные домены антител и антагонисты
EA201100070A1 (ru) Туберкулезный белок rv2386c, композиции и их применения
RU2016146198A (ru) Терапевтические dll4-связывающие белки
WO2015138907A3 (en) Hybrid immunoglobulin containing non-peptidyl linkage
GEP20146112B (en) Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and usage thereof
RU2015147300A (ru) Гуманизированные антитела к cxcr5, их производные и их применение
DE602004025101D1 (de) Humane anti-humane cd3-bindungsmoleküle
MX2009012949A (es) Anticuerpos humanizados que enlazan a ab (1-42) globulomero y usos de los mismos.
DE602005011617D1 (de) Hochaffiner ny-eso-t-zellen-rezeptor
EA200970131A1 (ru) Миметические антитела для glp-1 человека, композиции, способы и применения
EP2352523A4 (de) Verbesserte anti-cd19-antikörper
EP2202310A3 (de) Kaustisch stabile Chromatografie-Liganden
EA200601603A1 (ru) Миметические антитела glp-1 человека, композиции, способы и применения
CR11282A (es) Proteinas enlazadas al antigeno de celula de cepa mcdonough de felino humanas
EA201590525A1 (ru) Слитые белки для лечения метаболического синдрома
BR112012022102A2 (pt) polipeptídeos de ligação a a-beta.
UA108066C2 (uk) Білки, що зв'язуються з cgrp-рецепторами людини
UA113609C2 (xx) Антигензв'язуючий білок, який зв'язує людський il-23
BR112013017002A2 (pt) "proteínas mic não naturais, seu uso no tratamento de malignalidade ou infecção viral, bem como composição compreendendo as referidas proteínas"
DE602005008996D1 (de) Radiofluorierte peptide
NO20082510L (no) En fremgangsmate for konsentrasjon av et polypeptid
CY1116269T1 (el) Χρηση μιας πρωτεϊνης απο λουπινο
UA113623C2 (uk) Моноклональне антитіло проти інгібітору шляху тканинного фактора (tfpi)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties